Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 799

1.

A novel tissue-selective β2-adrenoceptor agonist with minimized cardiovascular effects, 5-HOB, attenuates neuropathic pain in mice.

Jourdain M, Hatakeyama S.

BMC Res Notes. 2019 Jul 15;12(1):413. doi: 10.1186/s13104-019-4466-y.

2.

Painful subcutaneous edema of the lumbar region in IgA vasculitis.

Shimizu A, Shimabukuro M, Shimizu M, Asai S, Tomizawa S, Hatakeyama S, Yamada Y.

Pediatr Int. 2019 Jun;61(6):624-625. doi: 10.1111/ped.13853. No abstract available.

PMID:
31242537
3.

Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.

Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, Yamada T, Yasunaga H.

J Infect Chemother. 2019 Jun 19. pii: S1341-321X(19)30162-X. doi: 10.1016/j.jiac.2019.05.027. [Epub ahead of print]

PMID:
31227381
4.

Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models.

Fukami S, Tomioka D, Murakami Y, Honda T, Hatakeyama S.

BMC Res Notes. 2019 Jun 18;12(1):347. doi: 10.1186/s13104-019-4389-7.

5.

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer.

Akamatsu S, Kubota M, Uozumi R, Narita S, Takahashi M, Mitsuzuka K, Hatakeyama S, Sakurai T, Kawamura S, Ishidoya S, Hoshi S, Ishida M, Mizuno K, Ogura K, Goto T, Terada N, Kobayashi T, Yamasaki T, Inoue T, Tsuchiya N, Ohyama C, Arai Y, Habuchi T, Morita S, Ogawa O.

Eur Urol Oncol. 2019 May;2(3):320-328. doi: 10.1016/j.euo.2018.10.011. Epub 2018 Nov 23.

PMID:
31200847
6.

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Yoneyama T, Tobisawa Y, Kaneko T, Kaya T, Hatakeyama S, Mori K, Sutoh Yoneyama M, Okubo T, Mitsuzuka K, Duivenvoorden W, Pinthus JH, Hashimoto Y, Ito A, Koie T, Suda Y, Gardiner RA, Ohyama C.

Cancer Sci. 2019 May 30. doi: 10.1111/cas.14082. [Epub ahead of print]

7.

Editorial Comment.

Hatakeyama S, Imai A, Ohyama C.

J Urol. 2019 Aug;202(2):359-360. doi: 10.1097/01.JU.0000559824.07845.4c. Epub 2019 Jul 8. No abstract available.

PMID:
31095466
8.

Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient.

Yamaguchi K, Shimizu E, Yamaguchi R, Imoto S, Komura M, Hatakeyama S, Noguchi R, Takane K, Ikenoue T, Gohda Y, Yano H, Miyano S, Furukawa Y.

J Hum Genet. 2019 Aug;64(8):729-740. doi: 10.1038/s10038-019-0611-7. Epub 2019 May 14.

PMID:
31089268
9.

Histoplasmosis among HIV-infected patients in Japan: A case report and literature review.

Hatakeyama S, Okamoto K, Ogura K, Sugita C, Nagi M.

Jpn J Infect Dis. 2019 Apr 26. doi: 10.7883/yoken.JJID.2018.354. [Epub ahead of print]

10.

Antibiotic prescription among outpatients in a prefecture of Japan, 2012-2013: a retrospective claims database study.

Hashimoto H, Matsui H, Sasabuchi Y, Yasunaga H, Kotani K, Nagai R, Hatakeyama S.

BMJ Open. 2019 Apr 3;9(4):e026251. doi: 10.1136/bmjopen-2018-026251.

11.

Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosis.

Yamaura T, Kasaoka T, Iijima N, Kimura M, Hatakeyama S.

BMC Res Notes. 2019 Apr 2;12(1):200. doi: 10.1186/s13104-019-4220-5.

12.

Total Synthesis of Lajollamycin B.

Nishimaru T, Eto K, Komine K, Ishihara J, Hatakeyama S.

Chemistry. 2019 Jun 12;25(33):7927-7934. doi: 10.1002/chem.201901069. Epub 2019 May 15.

PMID:
30924208
13.

Clinical Characteristics of Saffold Virus Infection in Children.

Ugai S, Iwaya A, Taneichi H, Hirokawa C, Aizawa Y, Hatakeyama S, Saitoh A.

Pediatr Infect Dis J. 2019 Aug;38(8):781-785. doi: 10.1097/INF.0000000000002298.

PMID:
30908431
14.

Significance of repeat magnetic resonance imaging in diagnosing vertebral osteomyelitis.

Kamiya N, Hatakeyama S, Kanda N, Yonaha S, Akine D, Yamamoto Y, Matsumura M.

J Gen Fam Med. 2018 Dec 20;20(2):68-71. doi: 10.1002/jgf2.226. eCollection 2019 Mar.

15.

Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β 2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies.

Koziczak-Holbro M, Rigel DF, Dumotier B, Sykes DA, Tsao J, Nguyen NH, Bösch J, Jourdain M, Flotte L, Adachi Y, Kiffe M, Azria M, Fairhurst RA, Charlton SJ, Richardson BP, Lach-Trifilieff E, Glass DJ, Ullrich T, Hatakeyama S.

J Pharmacol Exp Ther. 2019 May;369(2):188-199. doi: 10.1124/jpet.118.255307. Epub 2019 Feb 28.

PMID:
30819762
16.

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C.

Clin Exp Nephrol. 2019 Jun;23(6):807-813. doi: 10.1007/s10157-019-01710-z. Epub 2019 Feb 27.

PMID:
30809748
17.

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

Clin Genitourin Cancer. 2019 Jun;17(3):e440-e446. doi: 10.1016/j.clgc.2019.01.006. Epub 2019 Jan 17.

PMID:
30772204
18.

Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.

Hamano I, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C.

World J Urol. 2019 Feb 7. doi: 10.1007/s00345-019-02664-3. [Epub ahead of print]

PMID:
30729312
19.

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C.

Int J Urol. 2019 Apr;26(4):522-523. doi: 10.1111/iju.13908. Epub 2019 Jan 18. No abstract available.

PMID:
30659664
20.

A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates.

Suda T, Kanefuji T, Abe A, Nagayama I, Hoshi T, Morita S, Yagi K, Hatakeyama S, Hayatsu M, Hasegawa N, Terai S.

Medicine (Baltimore). 2019 Jan;98(2):e13958. doi: 10.1097/MD.0000000000013958.

21.

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.

Okamoto T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C.

World J Urol. 2018 Dec 4. doi: 10.1007/s00345-018-2590-2. [Epub ahead of print]

PMID:
30511214
22.

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C.

Med Oncol. 2018 Nov 26;36(1):7. doi: 10.1007/s12032-018-1232-2.

PMID:
30478763
23.

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

Med Oncol. 2018 Nov 24;36(1):6. doi: 10.1007/s12032-018-1231-3.

PMID:
30474747
24.

Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.

Kubota Y, Hatakeyama S, Narita I, Shimada M, Hashimoto Y, Ohyama C.

Int J Urol. 2019 Feb;26(2):309-311. doi: 10.1111/iju.13850. Epub 2018 Nov 14. No abstract available.

PMID:
30430663
25.

Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S.

Cancer Res. 2018 Dec 15;78(24):6795-6806. doi: 10.1158/0008-5472.CAN-18-1495. Epub 2018 Nov 2.

PMID:
30389700
26.

Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.

Matsumoto J, Takada S, Kinugawa S, Furihata T, Nambu H, Kakutani N, Tsuda M, Fukushima A, Yokota T, Tanaka S, Takahashi H, Watanabe M, Hatakeyama S, Matsumoto M, Nakayama KI, Otsuka Y, Sabe H, Tsutsui H, Anzai T.

Circulation. 2018 Oct 30;138(18):2064-2066. doi: 10.1161/CIRCULATIONAHA.118.035212. No abstract available.

PMID:
30372141
27.

Synthetic Studies on Spirolides A and B: Formation of the Upper Carbon Framework Based on a Lewis Acid Template-Catalyzed Diels-Alder Reaction.

Ishihara J, Usui F, Kurose T, Baba T, Kawaguchi Y, Watanabe Y, Hatakeyama S.

Chemistry. 2019 Jan 28;25(6):1543-1552. doi: 10.1002/chem.201804977. Epub 2018 Dec 20.

PMID:
30357942
28.

Whole-body vibration training improves the balance ability and leg strength of athletic throwers.

Takanashi Y, Chinen Y, Hatakeyama S.

J Sports Med Phys Fitness. 2018 Oct 10. doi: 10.23736/S0022-4707.18.09012-6. [Epub ahead of print]

PMID:
30317837
29.

Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C.

Transplant Proc. 2018 Oct;50(8):2553-2557. doi: 10.1016/j.transproceed.2018.02.182. Epub 2018 Mar 20.

PMID:
30316397
30.

LET dependence on killing effect and mutagenicity in the model filamentous fungus Neurospora crassa.

Ma L, Kazama Y, Hirano T, Morita R, Tanaka S, Abe T, Hatakeyama S.

Int J Radiat Biol. 2018 Dec;94(12):1125-1133. doi: 10.1080/09553002.2019.1524940. Epub 2018 Oct 11.

PMID:
30307372
31.

Tuberculous Peritonitis.

Okamoto K, Hatakeyama S.

N Engl J Med. 2018 Sep 20;379(12):e20. doi: 10.1056/NEJMicm1713168. No abstract available.

32.

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C.

Int Urol Nephrol. 2018 Nov;50(11):1999-2005. doi: 10.1007/s11255-018-1985-8. Epub 2018 Sep 18.

PMID:
30229466
33.

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.

BJU Int. 2019 May;123(5):877-884. doi: 10.1111/bju.14535. Epub 2018 Oct 15.

PMID:
30216623
34.

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Koie T, Ohyama C, Yoneyama T, Nagasaka H, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y.

Int J Med Robot. 2018 Dec;14(6):e1955. doi: 10.1002/rcs.1955. Epub 2018 Sep 14.

35.

Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Okamoto T, Tsutaya C, Hatakeyama S, Konishi S, Okita K, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C.

Int Urol Nephrol. 2018 Sep;50(9):1713-1720. doi: 10.1007/s11255-018-1957-z. Epub 2018 Aug 20.

PMID:
30128921
36.

[Effects of Serum Sodium Concentrations on Nausea and Vomiting after Moderately Emetogenic Chemotherapy].

Hatakeyama S, Suzuki N, Abe K, Konno N, Kaneko T, Toyoguchi T, Shiraishi T.

Yakugaku Zasshi. 2018;138(8):1095-1101. doi: 10.1248/yakushi.18-00009. Japanese.

37.

Morphologically poor blastocysts could affect the implantation rate of a morphologically good blastocyst during a double-blastocyst transfer for patients who have experienced repeated implantation failures.

Ohgi S, Taga Y, Anakubo H, Kurata Y, Hatakeyama S, Yanaihara A.

Reprod Med Biol. 2018 Apr 11;17(3):249-254. doi: 10.1002/rmb2.12097. eCollection 2018 Jul.

38.

False-positive elevation of 1,3-beta-D-glucan caused by continuous administration of penicillin G.

Ito S, Ashizawa M, Sasaki R, Ikeda T, Toda Y, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Yamamoto C, Fujiwara SI, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Suzuki J, Hatakeyama S, Morisawa Y, Yamada T, Kanda Y.

J Infect Chemother. 2018 Oct;24(10):812-814. doi: 10.1016/j.jiac.2018.06.008. Epub 2018 Jul 11.

PMID:
30006248
39.

Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts.

Jourdain M, Melly S, Summermatter S, Hatakeyama S.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):2415-2420. doi: 10.1016/j.bbrc.2018.06.170. Epub 2018 Jul 6.

PMID:
29969629
40.

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.

Okamoto T, Hatakeyama S, Hosogoe S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C.

PLoS One. 2018 Jul 3;13(7):e0199160. doi: 10.1371/journal.pone.0199160. eCollection 2018.

41.

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Hamano I, Hatakeyama S, Nakamura R, Fukuhara R, Noro D, Tanaka T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Yokoyama Y, Ohyama C.

Int J Urol. 2018 Sep;25(9):817-824. doi: 10.1111/iju.13732. Epub 2018 Jul 2.

PMID:
29963714
42.

Gastric syphilis: The great imitator in the stomach.

Okamoto K, Hatakeyama S, Umezawa M, Hayashi S.

IDCases. 2018 Mar 21;12:97-98. doi: 10.1016/j.idcr.2018.03.015. eCollection 2018.

43.

The Addition of a Head Rotation When the Ramped Position Fails to Provide Good Laryngeal Visualization: A Preliminary Study.

Ueda W, Hatakeyama S, Arai YP.

Anesth Pain Med. 2018 Feb 21;8(1):e63674. doi: 10.5812/aapm.63674. eCollection 2018 Feb.

44.

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Momota M, Hatakeyama S, Yamamoto H, Iwamura H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.

Oncotarget. 2018 May 1;9(33):23047-23057. doi: 10.18632/oncotarget.25198. eCollection 2018 May 1.

45.

Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.

Iwamura H, Hatakeyama S, Sato M, Ohyama C.

Med Oncol. 2018 May 9;35(6):94. doi: 10.1007/s12032-018-1152-1. Review.

46.

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.

Eur Urol Focus. 2018 May 4. pii: S2405-4569(18)30107-X. doi: 10.1016/j.euf.2018.04.017. [Epub ahead of print]

PMID:
29735367
47.

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.

Oncotarget. 2018 Apr 3;9(25):17396-17405. doi: 10.18632/oncotarget.24712. eCollection 2018 Apr 3.

48.

Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report.

Kido K, Hatakeyama S, Hamano I, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Tomita H, Suzuki T, Narumi S, Ohyama C.

Transplant Proc. 2018 Apr;50(3):898-901. doi: 10.1016/j.transproceed.2018.01.015.

PMID:
29661460
49.

Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Okamoto T, Hatakeyama S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Koie T, Suzuki T, Ohyama C.

Clin Exp Nephrol. 2018 Oct;22(5):1174-1181. doi: 10.1007/s10157-018-1569-z. Epub 2018 Mar 29.

PMID:
29600410
50.

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation.

Kodama H, Hatakeyama S, Matsumoto T, Tanaka T, Horiguchi H, Kubota Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.

Case Rep Urol. 2018 Jan 17;2018:6904827. doi: 10.1155/2018/6904827. eCollection 2018.

Supplemental Content

Loading ...
Support Center